J. Jay Boniface

6.8k total citations · 2 hit papers
48 papers, 5.4k citations indexed

About

J. Jay Boniface is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, J. Jay Boniface has authored 48 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 14 papers in Molecular Biology and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in J. Jay Boniface's work include T-cell and B-cell Immunology (15 papers), Monoclonal and Polyclonal Antibodies Research (14 papers) and Immune Cell Function and Interaction (13 papers). J. Jay Boniface is often cited by papers focused on T-cell and B-cell Immunology (15 papers), Monoclonal and Polyclonal Antibodies Research (14 papers) and Immune Cell Function and Interaction (13 papers). J. Jay Boniface collaborates with scholars based in United States, Germany and United Kingdom. J. Jay Boniface's co-authors include Mark M. Davis, Daniel S. Lyons, Ziv Reich, Johannes Hampl, Yueh‐hsiu Chien, Philip A. Reay, Peter A. Savage, Bernhard Arden, John M. Peltier and Moritz von Rechenberg and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

J. Jay Boniface

46 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

RAS–RAF–MEK-dependent oxidative cell death involving voltage-dependent anion channels

2007 1.3k citations Moritz von Rechenberg, Elma Zaganjor et al. Nature profile →
LIGAND RECOGNITION BY αβ T CELL RECEPTORS

1998 768 citations Mark M. Davis, J. Jay Boniface et al. profile →

Peers

Countries citing papers authored by J. Jay Boniface

Since Specialization

Citations

This map shows the geographic impact of J. Jay Boniface's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Jay Boniface with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Jay Boniface more than expected).

Fields of papers citing papers by J. Jay Boniface

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Jay Boniface. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Jay Boniface. The network helps show where J. Jay Boniface may publish in the future.

Co-authorship network of co-authors of J. Jay Boniface

This figure shows the co-authorship network connecting the top 25 collaborators of J. Jay Boniface. A scholar is included among the top collaborators of J. Jay Boniface based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Jay Boniface. J. Jay Boniface is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A dual-binding magnetic immunoassay to predict spontaneous preterm birth 2023 ·Frontiers in Bioengineering and Biotechnology ·(unknown), Andrew Gassman, Joshua V. Rosenberg, Matthew T.V. Chan, J. Jay Boniface, Anthony J. O’Donoghue, Louise C. Laurent, Drew A. Hall	2
2	Cost-Effectiveness of a Proteomic Test for Preterm Birth Prediction 2021 ·ClinicoEconomics and Outcomes Research ·Michael Grabner, Julja Burchard, (unknown), (unknown), (unknown), J. Jay Boniface, John A. F. Zupancic, Eric J. Stanek	9
3	512: Discovery and verification of maternal serum miRNA biomarkers predictive of preeclampsia 2018 ·American Journal of Obstetrics and Gynecology ·(unknown), Srimeenakshi Srinivasan, (unknown), (unknown), Trevor R. Leonardo, (unknown), (unknown), Angela Fox, Gladys A. Ramos, Hilary Roeder, Durlin E. Hickok, Julja Burchard, J. Jay Boniface, Louise C. Laurent	1
4	The building blocks of successful translation of proteomics to the clinic 2018 ·Current Opinion in Biotechnology ·Paul Kearney, J. Jay Boniface, Nathan D. Price, Leroy Hood	29
5	Analytical validation of protein biomarkers for risk of spontaneous preterm birth 2017 ·PubMed ·Chad Bradford, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Marija Mentinova, Daniel Chelsky, Stephen W. Hunsucker, Paul Kearney, Durlin E. Hickok, Tracey C. Fleischer, Ilia Ichetovkin, J. Jay Boniface, Gregory C. Critchfield, John M. Peltier	11
6	Abstract 2551: The Nampt inhibitor MPC-9528 synergizes with DNA damaging agents 2011 ·Cancer Research ·Ryan T. Terry-Lorenzo, (unknown), (unknown), J. Jay Boniface, Daniel Cimbora, Tracey C. Fleischer, Robert Carlson	1
7	Chemical Proteomics Identifies Nampt as the Target of CB30865, An Orphan Cytotoxic Compound 2010 ·Chemistry & Biology ·Tracey C. Fleischer, (unknown), Jeffrey S. Flick, Ryan T. Terry-Lorenzo, (unknown), Thaylon Davis, Rena McKinnon, Kirill Ostanin, J. Adam Willardsen, J. Jay Boniface	44
8	Analogues of 4-[(7-Bromo-2-methyl-4-oxo-3H-quinazolin-6-yl)methylprop-2-ynylamino]-N-(3-pyridylmethyl)benzamide (CB-30865) as Potent Inhibitors of Nicotinamide Phosphoribosyltransferase (Nampt) 2010 ·Journal of Medicinal Chemistry ·Jeffrey W. Lockman, (unknown), (unknown), (unknown), (unknown), (unknown), Kirill Ostanin, Jeremy Green, Rena McKinnon, Ryan T. Terry-Lorenzo, Tracey C. Fleischer, J. Jay Boniface, Mark D. Shenderovich, J. Adam Willardsen	20
9	RAS–RAF–MEK-dependent oxidative cell death involving voltage-dependent anion channels breakdown → 2007 ·Nature ·(unknown), Moritz von Rechenberg, Elma Zaganjor, Andras J. Bauer, Wan Seok Yang, Daniel J. Fridman, Adam J. Wolpaw, Inese Smukste, John M. Peltier, J. Jay Boniface, Richard A. Smith, Stephen L. Lessnick, Sudhir Sahasrabudhe, Brent R. Stockwell	1301
10	T Cell Receptor Biochemistry, Repertoire Selection and General Features of TCR and Ig Structure 2007 ·Novartis Foundation symposium ·Mark M. Davis, Daniel S. Lyons, John D. Altman, Michael G. McHeyzer‐Williams, Johannes Hampl, J. Jay Boniface, Yueh‐hsiu Chien	4
11	Conformational isomers of a class II MHC-peptide complex in solution 1999 ·Journal of Molecular Biology ·Lutz Schmitt, J. Jay Boniface, Mark M. Davis, Harden M. McConnell	46
12	Formation of a Highly Peptide-Receptive State of Class II MHC 1998 ·Immunity ·Joshua D. Rabinowitz, Marija Vrljic, Peter M. Kasson, Michael N. Liang, Robert Busch, J. Jay Boniface, Mark M. Davis, (unknown)	114
13	Initiation of Signal Transduction through the T Cell Receptor Requires the Multivalent Engagement of Peptide/MHC Ligands 1998 ·Immunity ·J. Jay Boniface, Joshua D. Rabinowitz, Christoph Wülfing, Johannes Hampl, Ziv Reich, John D. Altman, (unknown), Craig Beeson, Harden M. McConnell, Mark M. Davis	321
14	Ligand-specific oligomerization of T-cell receptor molecules 1997 ·Nature ·Ziv Reich, J. Jay Boniface, Daniel S. Lyons, Nina Borochov, Ellen Wachtel, Mark M. Davis	204
15	A TCR Binds to Antagonist Ligands with Lower Affinities and Faster Dissociation Rates Than to Agonists 1996 ·Immunity ·Daniel S. Lyons, (unknown), Johannes Hampl, J. Jay Boniface, Yueh‐hsiu Chien, Leslie J. Berg, Mark M. Davis	372
16	Evidence for a conformational change in a class II major histocompatibility complex molecule occurring in the same pH range where antigen binding is enhanced. 1996 ·The Journal of Experimental Medicine ·J. Jay Boniface, Daniel S. Lyons, Dániel Wettstein, Nancy L. Allbritton, Mark M. Davis	51
17	T‐Cell Recognition of Antigen 1995 ·Annals of the New York Academy of Sciences ·J. Jay Boniface, Mark M. Davis	9
18	Engineering and expression of a secreted murine TCR with reduced N -linked glycosylation. 1994 ·The Journal of Immunology ·Roland K. Strong, David M. Penny, R. M. Renny Feldman, Leslie P. Weiner, J. Jay Boniface, Mark M. Davis, Pamela J. Björkman	11
19	Two-dimensional Nuclear Magnetic Resonance Analysis of a Labeled Peptide Bound to a Class II Major Histocompatibility Complex Molecule 1993 ·Journal of Molecular Biology ·Paul C. Driscoll, John D. Altman, J. Jay Boniface, Kazuyasu Sakaguchi, Philip A. Reay, James G. Omichinski, Ettore Appella, Mark M. Davis	18
20	Expression of a class II major histocompatibility complex (MHC) heterodimer in a lipid-linked form with enhanced peptide/soluble MHC complex formation at low pH. 1991 ·The Journal of Experimental Medicine ·Dániel Wettstein, J. Jay Boniface, Philip A. Reay, Hansjörg Schild, Mark M. Davis	136

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact